These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Establishment of Primary Cell Culture From Ascitic Fluid and Solid Tumor Obtained From Epithelial Ovarian Carcinoma Patients. Kar R; Chawla D; Gupta B; Mehndiratta M; Wadhwa N; Agarwal R Int J Gynecol Cancer; 2017 Nov; 27(9):2000-2005. PubMed ID: 28816710 [TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer stem cells enrichment. Yang L; Lai D Methods Mol Biol; 2013; 1049():337-45. PubMed ID: 23913228 [TBL] [Abstract][Full Text] [Related]
5. Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC). Zietarska M; Maugard CM; Filali-Mouhim A; Alam-Fahmy M; Tonin PN; Provencher DM; Mes-Masson AM Mol Carcinog; 2007 Oct; 46(10):872-85. PubMed ID: 17455221 [TBL] [Abstract][Full Text] [Related]
6. Presence of both Mesenchymal and Carcinomatous Features in an In-vitro Model of Ovarian Carcinosarcoma Derived from Patients' Ascitic Fluid. Shariftabrizi A; Pellicciotta I; Abdullah A; Venditti CA; Samuelson R; Shahabi S Int J Hematol Oncol Stem Cell Res; 2015 Jan; 9(1):1-4. PubMed ID: 25802693 [TBL] [Abstract][Full Text] [Related]
7. Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer. Provencher DM; Finstad CL; Saigo PE; Rubin SC; Hoskins WJ; Federici MG; Stockert E; Lloyd KO; Lewis JL Gynecol Oncol; 1993 Jul; 50(1):78-83. PubMed ID: 8349167 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150 [TBL] [Abstract][Full Text] [Related]
9. Isolation and culture of ovarian cancer cells and cell lines. Kurbacher CM; Korn C; Dexel S; Schween U; Kurbacher JA; Reichelt R; Arenz PN Methods Mol Biol; 2011; 731():161-80. PubMed ID: 21516407 [TBL] [Abstract][Full Text] [Related]
10. Primary cultures of normal and tumoral human ovarian epithelium: a powerful tool for basic molecular studies. Lounis H; Provencher D; Godbout C; Fink D; Milot MJ; Mes-Masson AM Exp Cell Res; 1994 Dec; 215(2):303-9. PubMed ID: 7526992 [TBL] [Abstract][Full Text] [Related]
11. An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites. Barker SD; Casado E; Gomez-Navarro J; Xiang J; Arafat W; Mahasreshti P; Pustilnik TB; Hemminki A; Siegal GP; Alvarez RD; Curiel DT Gynecol Oncol; 2001 Jul; 82(1):57-63. PubMed ID: 11426962 [TBL] [Abstract][Full Text] [Related]
12. 14-3-3 zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients. Kobayashi R; Deavers M; Patenia R; Rice-Stitt T; Halbe J; Gallardo S; Freedman RS Cancer Immunol Immunother; 2009 Feb; 58(2):247-58. PubMed ID: 18618111 [TBL] [Abstract][Full Text] [Related]
13. Establishment, characterization and downstream application of primary ovarian cancer cells derived from solid tumors. Sueblinvong T; Ghebre R; Iizuka Y; Pambuccian SE; Isaksson Vogel R; Skubitz AP; Bazzaro M PLoS One; 2012; 7(11):e50519. PubMed ID: 23226302 [TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers. Verschraegen CF; Hu W; Du Y; Mendoza J; Early J; Deavers M; Freedman RS; Bast RC; Kudelka AP; Kavanagh JJ; Giovanella BC Clin Cancer Res; 2003 Feb; 9(2):845-52. PubMed ID: 12576458 [TBL] [Abstract][Full Text] [Related]
15. [The comparison of biological characteristics between tumor-infiltrating lymphocytes and tumor-associated lymphocytes in ascites of epithelial ovarian carcinoma]. Kang S; Shen K; Lang J Zhonghua Fu Chan Ke Za Zhi; 1998 Oct; 33(10):607-10. PubMed ID: 10806687 [TBL] [Abstract][Full Text] [Related]
16. Comparison of cellular phenotypes in tumor cyst and ascitic fluid from ovarian serous carcinoma. Harlozinska A; Bar JK; Richter R; Cislo M Acta Cytol; 1992; 36(6):869-74. PubMed ID: 1449024 [TBL] [Abstract][Full Text] [Related]
17. Further experience in testing the sensitivity of human ovarian carcinoma cells to interferon in an in vitro semisolid agar culture system: comparison of solid and ascitic forms of the tumor. Epstein LB; Shen JT; Abele JS; Reese CC Prog Clin Biol Res; 1980; 48():277-90. PubMed ID: 6163159 [TBL] [Abstract][Full Text] [Related]
18. Angiogenic protein expression in advanced epithelial ovarian cancer. Barton DP; Cai A; Wendt K; Young M; Gamero A; De Cesare S Clin Cancer Res; 1997 Sep; 3(9):1579-86. PubMed ID: 9815846 [TBL] [Abstract][Full Text] [Related]
19. Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer. Greenaway J; Moorehead R; Shaw P; Petrik J Gynecol Oncol; 2008 Feb; 108(2):385-94. PubMed ID: 18036641 [TBL] [Abstract][Full Text] [Related]
20. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance. Wang L; Ma J; Liu F; Yu Q; Chu G; Perkins AC; Li Y Gynecol Oncol; 2007 Jun; 105(3):695-702. PubMed ID: 17368732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]